Antibody, 21D8 was cloned and expressed as a chimeric murine-human antibody. The chimeric antibody accelerates the decarboxylation of 5-nitro-3-carboxybenzisoxazole with a catalytic rate constant (kcat) of 0.96 sÿ1 and a Michaelis constant (Km) of 5.0 mM.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-S0009-YC | Human Anti-C8H4N2O5 Recombinant Antibody (clone 21D8) | Catalyze | Human IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-S0009-YC-F(E) | Human Anti-C8H4N2O5 Recombinant Antibody (clone 21D8); Fab Fragment | Catalyze | Human Fab |
There are currently no Customer reviews or questions for HPAB-S0009-YC-S(P). Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.